| Literature DB >> 35197758 |
Nezar Boreak1, Shilpa Bhandi1.
Abstract
Emerging clinical evidences highlight the association of Interleukin-8 (IL8) with endodontic pulpitis. Relatively higher expression of IL8 has been found in the pulp samples of pulpitis patients with moderate/severe pain. It is speculated that IL8 can be considered as a potential target for therapeutics of endodontic pulpitis. A library consisting of 3072 small molecules from the ZINC database was used to identify potential lead molecules with drug-like properties against the IL8. Based on the in-silico structure-assisted drug designing involving molecular docking, MD simulations, and MMPBSA analyses, we found a small molecule ZINC14613097 inhibits IL8. This study provides a new lead molecule than can be further validated in in-vitro, in-vivo, and ongoing clinical studies for the therapeutic management of endodontic pulpitis.Entities:
Keywords: Endodontic; Inhibitor; Interleukin-8; Pulpitis; ZINC14613097
Year: 2021 PMID: 35197758 PMCID: PMC8848128 DOI: 10.1016/j.sjbs.2021.10.015
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.219
Fig. 1(a) Cartoon representation (violet color) of IL-8 (PDB ID: 5d14). (b) Superimposed structure of IL-8 after energy minimization (native in violet color and energy minimized structure in cyan color).
Top ten small molecules having high binding affinity to IL8 and the binding parameters.
| S.No. | Small molecules | Target | Binding | Inhibition |
|---|---|---|---|---|
| molecule | affinity | constant, Ki | ||
| (kcal/Mol) | (nM) | |||
| 1. | ZINC14613097 | −9.7 | 4.19575E-07 | |
| 2. | ZINC01482077 | −8.3 | 8.24165E-07 | |
| 3. | ZINC00000061 | −7.7 | 2.26893E-06 | |
| 4. | ZINC08551464 | −8.1 | 1.15509E-06 | |
| 5. | ZINC00896717 | IL8 | −8.1 | 1.15509E-06 |
| 6. | ZINC03830793 | −7.6 | 2.6861E-06 | |
| 7. | ZINC00004351 | −7.6 | 2.6861E-06 | |
| 8. | ZINC03830326 | −7.4 | 3.76464E-06 | |
| 9. | ZINC03830332 | −7.2 | 5.27625E-06 | |
| 10. | ZINC03831537 | −7.2 | 5.27625E-06 |
Fig. 2Structure of small molecule ZINC14613097.
Fig. 3a-d. The crystal structure of IL8 in complex with ZINC14613097. (a) A cartoon representation of IL8-ZINC14613097 complex. (b) Surface representation of IL8-ZINC14613097complex. ZINC14613097 is represented as coloured sticks. (c) A zoomed view of substrate binding pocket of IL8 representing the key amino acid residues forming interactions with inhibitor molecule ZINC14613097 (d) Surface representation of conserved substrate-binding pocket of IL8.
Calculated MD parameters for IL8 and IL8-ZINC14613097 systems obtained after simulation.
| Average | Average | Average | Average | Kinetic | Potential | Enthalpy | Volume | Density | |
|---|---|---|---|---|---|---|---|---|---|
| RMSD | RMSF | SASA | Energy | energy | kJ/mol | (nm3) | (kg/m3) | ||
| (nm) | (nm) | (nm) | (nm2) | (kJ/mol) | (kJ/mol) | ||||
| IL8 | 0.325722 | 0.165734 | 1.24268 | 57.1367 | 56160.4 | −337696 | −281522 | −220.338 | 1015.78 |
| IL8- | 0.404839 | 0.173671 | 1.27579 | 56.6026 | 39341.9 | −203177 | −163826 | −155.742 | 1005.74 |
| ZINC14613097 | |||||||||
| complex |
Fig. 4a-d: Structural dynamics of IL8 up on ZINC14613097 binding. (a) RMSD plot of IL8 and IL8-ZINC14613097 complex as a function of time. (b) RMSF plot of free IL8 and upon silmitasertib binding. (c) Time evolution of radius of gyration of IL8 and IL8-ZINC14613097 complex. (d) SASA plot of IL8 and IL8-ZINC14613097 complex as a function of time. The values were obtained from 50 ns MD simulations time scale. Black and red represents values obtained for free IL8 and IL8-ZINC14613097 complex, respectively.
MM-PBSA calculations of binding free energy for IL8-ZINC14613097 complex.
| Complex | Ebinding (kj/mol) | SASA (kj/mol) | Epolar solvation (kj/mol) | EElectrostatic (kj/mol) | EVan der Waal (kj/mol) |
|---|---|---|---|---|---|
| IL8-ZINC14613097 | 215.223 ± 14.124 | 24.921 ± 1.383 | 141.215 ± 15.418 | 53.281 ± 12.329 | 271.827 ± 19.215 |
| complex. |